EBMT 2025: Exciting Updates and Advancements in AlloHSCT
June 18th 2025
Panelists discuss key updates from EBMT (European Society for Blood and Marrow Transplantation) 2025, including advancements in immune reconstitution, novel graft-vs-host disease (GVHD) prophylaxis strategies, and addressing ongoing unmet needs in allogeneic hematopoietic stem cell transplantation (alloHSCT), such as improved infection control, GVHD prevention, and enhancing long-term survival and quality of life.